January 17, 2026 a 08:38 am
HSIC: Analysts Ratings - Henry Schein, Inc.
Henry Schein, Inc. has been a consistent performer in the healthcare sector, offering a variety of products and services to a wide array of customers. With stable operating segments, the stock remains a point of focus for investors. Recent analyst ratings reflect cautious optimism, with a notable inclination towards holding positions.
Historical Stock Grades
The latest analyst ratings for HSIC reveal a predominantly cautious stance with a majority of analysts suggesting a "Hold." This indicates a consensus view that the stock is currently fairly valued.
| Rating | Number of Analysts | Score |
|---|---|---|
| Strong Buy | 4 | |
| Buy | 2 | |
| Hold | 9 | |
| Sell | 1 | |
| Strong Sell | 0 |
Sentiment Development
The sentiment for HSIC has shown stability in recent months, with a consistent level of "Hold" ratings prevailing. There has been a slight uptick in "Strong Buy" recommendations, indicating potential undervaluation recognized by some analysts.
- The overall number of ratings has remained stable.
- "Strong Buy" ratings saw a slight increase, indicating heightened optimism from a few analysts.
- "Hold" ratings continue to dominate, reflecting a consensus of stable, yet cautious outlook.
Percentage Trends
Analyzing the percentage trends reveals a slight shift towards more conservative holdings. While "Strong Buy" recommendations slightly increased, "Buy" stayed relatively constant, suggesting guarded optimism.
- The proportion of "Hold" recommendations has remained high.
- A small increase in "Strong Buy" ratings shows faith in potential growth prospects.
- Buy and Sell ratings have stayed consistent without significant monthly shifts.
Latest Analyst Recommendations
Recent ratings showcase consistency in sentiment, with leading financial institutions maintaining their existing outlooks. This emphasizes a conservative approach towards the stock amidst stable market conditions.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-11-05 | Overweight | Overweight | JP Morgan |
| 2025-11-05 | Outperform | Outperform | Evercore ISI Group |
| 2025-11-05 | Equal Weight | Equal Weight | Wells Fargo |
| 2025-11-05 | Underweight | Underweight | Morgan Stanley |
| 2025-11-05 | Outperform | Outperform | Barrington Research |
Analyst Recommendations with Change of Opinion
There have been strategic adjustments by some analysts, indicating shifts in market perceptions. Upgrades and downgrades reflect nuanced evaluations of HSIC's market position.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-08-26 | Outperform | In Line | Evercore ISI Group |
| 2025-07-25 | Hold | Buy | Stifel |
| 2025-07-14 | Neutral | Outperform | Baird |
| 2025-01-06 | Buy | Underperform | B of A Securities |
| 2024-07-22 | Outperform | Neutral | Baird |
Interpretation
The stability in analyst ratings suggests a balanced view of Henry Schein, Inc., with neither overwhelming confidence nor pronounced caution. The presence of "Hold" and consistent ratings indicates perceived fair value. However, recent upgrades and downgrades hint at potential shifts in market dynamics. The market appears stable with a cautious outlook, reflecting broader economic uncertainties. Such trends underscore a gradual adaptation to changing market conditions and competitive pressures.
Conclusion
In summary, Henry Schein, Inc. maintains a stable position within the healthcare sector, backed by consistent yet conservative analyst ratings. The mix of "Hold" and "Buy" recommendations suggests a balanced but cautious optimism among analysts. Minor upgrades and downgrades reflect careful strategic adjustments. Opportunities may exist, particularly in light of the company's extensive product and service portfolio. However, market conditions remain a critical factor, and investors should weigh these dynamics carefully when considering HSIC. The company's adaptability and consistent operational focus provide a solid foundation amidst evolving market landscapes.